大禹節水(300021.SZ):聯合體預中標郟縣廣闊渠和恆壓灌區提質增效(一期)項目
格隆匯6月11日丨大禹節水(300021.SZ)宣佈,2020年6月10日,河南省政府採購網發佈《郟縣水利局關於對廣闊渠和恆壓灌區提質增效(一期)項目社會資本方採購預中標結果公告》,公司參股公司河南水谷科技有限公司、公司全資子公司甘肅大禹節水集團水利水電工程有限責任公司以及河南省水利第二工程局作為聯合體成員為《郟縣廣闊渠和恆壓灌區提質增效(一期)項目》的預中標社會資本方。項目投資規模約為3.73億元;項目運作模式為BOT(建設-運營-移交);項目合作期為20年,其中建設期為2年,運營期為18年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.